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Abstract
Background: Power morcellation has become a common technique for the minimally invasive resection of uterine
leiomyomas. This technique is associated with dissemination of cellular material throughout the peritoneum. When
morcellated uterine tumors are unexpectedly found to be leiomyosarcomas or tumors with atypical features (atypical
leiomyoma, smooth muscle tumor of uncertain malignant potential), there may be significant clinical consequences. This
study was undertaken to determine the frequency and clinical consequence of intraperitoneal dissemination of these
neoplasms.
Methodology/Principal Findings: From 2005–2010, 1091 instances of uterine morcellation were identified at BWH.
Unexpected diagnoses of leiomyoma variants or atypical and malignant smooth muscle tumors occurred in 1.2% of cases
using power morcellation for uterine masses clinically presumed to be ‘‘fibroids’’ over this period, including one endometrial
stromal sarcoma (ESS), one cellular leiomyoma (CL), six atypical leiomyomas (AL), three smooth muscle tumor of uncertain
malignant potential (STUMPs), and one leiomyosarcoma (LMS). The rate of unexpected sarcoma after the laparoscopic
morcellation procedure was 0.09%, 9-fold higher than the rate currently quoted to patients during pre-procedure briefing,
and this rate may increase over time as diagnostically challenging or under-sampled tumors manifest their biological
potential. Furthermore, when examining follow-up laparoscopies, both from in-house and consultation cases, disseminated
disease occurred in 64.3% of all tumors (zero of one ESS, one of one CL, zero of one AL, four of four STUMPs, and four of
seven LMS). Only disseminated leiomyosarcoma, however, was associated with mortality. Procedures are proposed for
pathologic evaluation of morcellation specimens and associated follow-up specimens.
Conclusions/Significance: While additional study is warranted, these data suggest uterine morcellation carries a risk of
disseminating unexpected malignancy with apparent associated increase in mortality much higher than appreciated
currently.
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Introduction
Uterine leiomyomas (‘‘fibroids’’) are common benign uterine
neoplasms associated with dysmenorrhea, menorrhagia, pelvic
pain and pressure. Surgical procedures commonly employed to
treat symptomatic uterine fibroids include myomectomy or sub-
total hysterectomy. When performed using minimally invasive
techniques, these procedures can be performed on a day surgical
basis with limited disability. In order to remove these bulky lesions
from the abdominal cavity through laparoscopic ports the tumors
must be morcellated [1]. This technique involves fragmenting the
lesion such that it can pass through a small incision (i.e. the
laparoscope port itself). Originally performed by hand with the
assistance of a laparoscopic scalpel, newer methods involve the use
of power morcellators, devices designed to draw the lesions into a
whirling blade, which then generates small (approximately 1 cm
diameter) cores of the lesion, capable of being removed through
the port incision. The velocity with which these blades spin has
been associated with dispersal of microscopic tumor fragments,
thus potentially seeding the peritoneum with small pieces of both
neoplastic and non-neoplastic material. This phenomenon is
compounded with the fact that some morcellated tumors are not
benign [2]. The purpose of this study was to determine the
frequency of a post-operative histologic diagnosis of malignancy
(leiomyosarcoma), problematic smooth muscle tumors (atypical
leiomyoma, smooth muscle tumor of uncertain malignant
potential), or variant leiomyomas (e.g. cellular leiomyoma)
following power morcellation at a major urban academic medical
center, where over 1,000 hysterectomies are performed annually
[3]. Additionally, this study determined the frequency of iatrogenic
peritoneal dissemination of these lesions secondary to power
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e50058morcellation and the clinical outcomes data associated with such
complications.
Methods
Ethics Statement
All materials from this study were collected in the course of
clinical care prior to the start of any research. Research was
performed only on discarded tissue, i.e. material deemed not
necessary for clinical diagnostics or care. Clinical information used
in the study was entirely anonymized from the medical record in
accordance with current national guidelines. The Institutional
Review Board at Brigham & Women’s Hospital evaluated and
approved all aspects of this research, and deemed the procedure
eligible for expedited review not requiring subject consent.
Case Acquisition
The electronic medical records of the Brigham & Women’s
Hospital (BWH) Department of Pathology were searched for cases,
both in-house and consultation, including the keywords ‘‘morcel-
lation’’ or ‘‘morcellated’’ in association with at least one of the
following keywords: myomectomy, fibroid, fibroids, leiomyoma,
leiomyomas, leiomyomata, myoma, myomas. Additional cases
were identified that contained the keyword ‘‘morcellation’’ or
‘‘morcellated’’ as well as the keyword ‘‘uterus’’, and that were
performed for the indication of uterine leiomyoma, as per the
medical record. The search term ‘‘leiomyosarcoma’’ was omitted
to avoid case selection bias; however, when this term was included,
no additional cases meeting study criteria were identified.
Specimen Evaluation
Histologic evaluation of morcellated specimens was performed
by taking one section of tissue for every 1 cm of the original
radiologically reported greatest dimension of the lesion. This was
felt to best recapitulate the degree of sampling that would be
performed on an equivalent en bloc resection. Diagnoses were
rendered as per currently accepted guidelines [4,5], and included
leiomyoma (leio), cellular leiomyoma (CL), atypical leiomyoma
(AL), smooth muscle tumor of uncertain malignant potential
(STUMP), leiomyosarcoma (LMS), and endometrial stromal
sarcoma (ESS). Representative images of cases diagnosed as
leiomyoma (case previously published) [6], atypical leiomyoma
(case #7), STUMP (case #11), and LMS (case #15) are shown in
Figure 1.
Figure 1. Representative histologic fields of several of the most common diagnoses reviewed during this study. Leiomyoma (case
previously published) [6] is characterized by smooth muscle cells without atypia, mitoses, or necrosis. In contrast, atypical leiomyoma (case #7)
shows atypia, but rare mitoses (up to 2 mitoses per 10 high power fields). Smooth muscle tumor of uncertain malignant potential (STUMP, case #11)
is characterized by a higher rate of mitoses (3 to 8 mitoses per 10 high power fields) and more frequent atypia. Leiomyosarcoma (LMS, case #15)
shows significant mitotic activity (over 10 mitoses per 10 high power fields), prominent atypia, and tumor necrosis.
doi:10.1371/journal.pone.0050058.g001
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Simple statistics were calculated using the R statistical package.
Proportion confidence intervals were calculated using the Wilson
method, chosen in light of the small sample sizes in some analyses.
Continuous variable confidence intervals were calculated using
Student’s t-distribution.
Results
Unexpected Diagnoses at the Time of Morcellation
From 2005 to 2010, a total of 1091 cases of morcellation were
performed at BWH for the indication of uterine leiomyoma.
Expert gynecologic pathologists of the Division of Women’s and
Perinatal Pathology reviewed tissues from all resections.
Of the 1091 morcellated surgical resections for clinically
presumed leiomyoma, thirteen cases were diagnosed as clinically
Figure 2. Unexpected diagnosis of leiomyoma variants, atypia, or malignancy following morcellation performed at BWH for
clinically presumed uterine leiomyoma.
doi:10.1371/journal.pone.0050058.g002
Table 1. Unexpected diagnoses following uterine power morcellation for suspected leiomyoma.
Case # Age Diagnosis Radiologic Size (cm) Gross Weight (g) Follow-Up (mos.)
1 48 ESS 8.2 hysterectomy, 322 g 34
2 36 CL 9.7 357 71
3 31 AL multiple, up to 2.5 cm 382 35
4 35 AL multiple, up to 8 cm 473 1
5 37 AL 8.0 292 41
6 40 AL multiple hysterectomy, 605 g n/a
7 43 AL 8.0 hysterectomy, 1245 g 6
8 61 AL multiple, up to 10 cm hysterectomy, 588 g 32
9 24 STUMP 6.6 120 12
10 41 STUMP 10.0 350 13
11 45 STUMP multiple, up to 8.7 cm hysterectomy, 422 g 28
12 42 LMS multiple, up to 6.2 cm 139 42
Abbreviations – ESS: endometrial stromal sarcoma; CL: cellular leiomyoma; AL: atypical (a.k.a. symplastic) leiomyoma; STUMP: smooth muscle tumor of uncertain
malignant potential; LMS: leiomyosarcoma; n/a: not available.
doi:10.1371/journal.pone.0050058.t001
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histopathologic examination (summarized in Figure 2 and Table 1);
all of these cases were found to have been morcellated using a
laparoscopic power morcellator. This represents an estimated
aggregate incidence of unexpected variants, atypia, and malig-
nancy of 1.2% (95% confidence interval 0.7–2.0%). The ages of
patients (range from 36 to 42 years old) did not differ appreciably
when grouped by diagnosis. Lesion size was variable, but most of
the atypical or malignant lesions were large (over 6 cm); there was
a mix of solitary and multiple lesions in all diagnostic categories.
Grossly, atypical and malignant lesions occasionally showed yellow
coloration, ‘‘degenerative’’ changes, or hemorrhage, but many
lesions were not grossly distinguishable from benign leiomyomas.
Peritoneal Dissemination of Morcellation Lesions
For a subset of cases with unexpected diagnoses at the time of
morcellation, follow-up clinical procedures were performed to
Figure 3. Follow-up exploratory laparoscopy in cases of uterine morcellation with unexpected diagnoses.
doi:10.1371/journal.pone.0050058.g003
Table 2. Summary of cases of uterine power morcellation with follow-up exploratory laparotomy.
First Peritoneal Dx Subsequent Peritoneal Dx Clinical Follow-Up
Case # Initial Age Initial Dx Dx Interval* Dx Interval* Prolif. Index** Status Treatment Interval*
1 48 ESS – 1 Alive none 34
2 36 CL CL 12 LG sarcoma 18 10% Alive arom 71
7 43 AL – 5 Alive none 6
9 24 STUMP STUMP 3 1% Alive none 12
10 41 STUMP STUMP 2 Alive none 13
11 45 STUMP STUMP 2 40% Alive none 28
13 27 STUMP STUMP 78 Alive none 93
12 42 LMS *** 1 5%** Alive chemo 42
14 43 LMS – 1 Alive none 38
15 47 LMS LMS 1 Deceased chemo 17
16 48 LMS – 1 Alive none 9
17 49 LMS LMS 16 Alive chemo 39
18 58 LMS Leio 1 LMS 6 80% Deceased arom/rads 27
19 68 LMS LMS 13 Deceased chemo 29
*Intervals are in months.
**Proliferation indices are measured by MiB-1/Ki-67 staining on the most recently sampled clinical material.
***While no disseminated disease was identified, residual LMS was identified at the site of the prior hysterectomy. This case is not included in the total number of cases
with disseminated disease.
Abbreviations – Dx: diagnosis; ESS: endometrial stromal sarcoma; CL: cellular leiomyoma; AL: atypical (a.k.a. symplastic) leiomyoma; STUMP: smooth muscle tumor of
uncertain malignant potential; LMS: leiomyosarcoma; DPL: disseminated peritoneal leiomyomatosis; LG: low grade; arom: aromatase inhibitor therapy; chemo: classic
antineoplastic chemotherapy; rads: radiotherapy.
doi:10.1371/journal.pone.0050058.t002
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doi:10.1371/journal.pone.0050058.g004
Figure 5. A case of leiomyosarcoma (case #17) diagnosed following a uterine power morcellation, with subsequent diagnosis of
dissemination throughout the peritoneum (all images 100x magnification). The primary and disseminated lesions are characterized by very
high mitotic rates (all lesions greater than 50 mitoses per 10 high power fields) and significant nuclear atypia and pleomorphism; focal necrosis was
also appreciated (not shown).
doi:10.1371/journal.pone.0050058.g005
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quent to an unexpected primary diagnosis.
Exploratory laparoscopy was performed in seven of twelve in-
house cases described above; original diagnoses in these cases
included one ESS, one CL, one AL, three STUMPs, and one
LMS. Searching the consult records of BWH for cases where the
original morcellation procedure was performed at an outside
institution but where tissue from a follow-up laparoscopy was
available for review at BWH revealed an additional seven cases of
power morcellated uterine mesenchymal lesions originally diag-
nosed with unexpected atypia or malignancy.
All cases with follow-up, including the seven in-house resections
and seven outside hospital resections, were examined to determine
if the lesion that had been morcellated could be found
disseminated throughout the peritoneum. Of these fourteen cases,
nine had documented dissemination (summarized in Figure 3 and
Table 2); these data represent an estimated occurrence of
morcellator-based dissemination of 64.3% (95% confidence
interval 38.8–83.7%). These lesions were grossly visible intraop-
eratively (Figure 4). Histologically, these lesions were characterized
by smooth muscle tissue adjacent to serosal/peritoneal surfaces
(Figures 5 and 6).
Disseminated lesions did not show any definite infiltration or
invasion of adjacent tissue. Consequently, presence or absence of
significant cytologic atypia, mitoses, and necrosis were the basis for
determining whether the disseminated tissue represented a benign,
atypical, or malignant lesion. In a small number of cases,
immunohistochemical staining for smooth muscle actin and/or
desmin was used to confirm further that the lesions represented
smooth muscle rather than a reactive fibroblastic proliferation.
Proliferation indices (MiB-1/Ki-67 staining) were also evaluated
in some of these lesions. Material from a case of iatrogenic
disseminated peritoneal leiomyomatosis (DPL) following uterine
morcellation showed a proliferation index of 1% [6]. A similar
proliferation index was identified in one case of disseminated
STUMP (case #9). In contrast, another case of STUMP showed a
proliferation index of 40% (case #11). Residual LMS in case #12
showed a proliferative index of 5%. Disseminated sarcoma showed
proliferative indices of 10% (case #2) and 80% (case #18).
Follow-up clinical data showed that the only mortality in this
case series occurred in patients with diagnoses of leiomyosarcoma;
all other patients remain alive at last follow-up. Of the seven LMS
cases for which follow-up was available, four showed evidence of
peritoneal dissemination (57.1%, 95% confidence internal 25.0–
84.2%). Of these, three patients have died (75%, 95% confidence
internal 30.1–98.7%), with an average post-diagnosis survival of
24.3 months (95% confidence interval 8.4–40.3 months). The
remaining patient with documented dissemination was alive at 39
months, and the cases without dissemination were alive with an
average follow-up interval of 29.7 months, including one case
(#12) with residual LMS identified at the site of prior hysterec-
tomy on re-exploration but without any evidence of disseminated
disease.
Discussion
Power morcellation, while an effective technique to facilitate
minimally invasive surgery of even large uterine masses, carries
a risk of dispersing the tumor into the peritoneal cavity. This is
particularly concerning considering the inevitable albeit uncom-
mon occurrence of a potentially malignant tumor that is
preoperatively misclassified and morcellated on the assumption
that it is benign [7–9]. The findings presented here add to the
existing literature of case reports of both non-neoplastic and
neoplastic tissues being disseminated throughout the peritoneum
as a result of power morcellation, including tissue of both
endometrial (endometrium, endometriosis, endometrial adeno-
carcinoma, stromal sarcoma) and myometrial (myometrium and
the spectrum of smooth muscle neoplasms) origin [6,10–21]. Of
note, one of the 1078 cases of uterine morcellations performed
at BWH with a post-operative diagnosis of leiomyoma has
previously been described as being associated with subsequent
development of disseminated peritoneal leiomyomatosis (DPL)
[6]. Despite these multiple case reports, no prospective study of
these complications has been performed to date.
Unexpected Diagnoses at the Time of Morcellation
The data in this study show that unexpected diagnoses of
variant leiomyoma, atypia, or malignancy will occur in approx-
Figure 6. A case of STUMP with peritoneal dissemination (case #11) showing implantation into the omentum. The primary lesion
showed scattered marked nuclear atypia and up to 9 mitoses per 10 high power fields; disseminated lesions showed nuclear pleomorphism and
atypia as well as increased proliferation indices (40% by MiB-1/Ki-67 staining), but mitoses were not prominent.
doi:10.1371/journal.pone.0050058.g006
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uterine leiomyoma. The in-house incidence of unexpected
leiomyosarcoma was 0.09% (95% confidence interval 0.00–
0.52%). This rate is similar to that reported by Leibsohn et al.
[2], but much higher than the empiric rate of 1-in-10,000 typically
quoted to patients during their pre-procedure briefing.
This estimate, however, may be limited by the assumption that
all cases of atypia or malignancy were identified in the original
morcellation specimens. One of the cases (#2) studied herein,
however, challenges this assumption in that the primary diagnosis
was cellular leiomyoma, but the patient later presented with low-
grade sarcoma in the peritoneum. It is not possible to know
whether this represents transformation after dissemination or if the
original specimen contained unsampled sarcoma. At this time, this
is the only case in this series in which an unappreciated diagnosis
in the original specimen has come to clinical attention, but the
actual incidence of unexpected atypia may be higher than the
stated estimate.
Of note, this study likely included some morcellations
performed by hand rather than with a power morcellator due to
the methods of case identification. All cases of unexpected
diagnoses were confirmed to have been performed by power
morcellation, and as such the actual incidence of unexpected
diagnoses associated with this procedure may be slightly higher
than the values stated.
Peritoneal Dissemination of Morcellation Lesions
The data demonstrate that following power morcellation with
an unexpected diagnosis of leiomyoma variant, atypia, or
malignancy, exploratory laparoscopy will find evidence of
peritoneal dissemination 64.3% of the time. Of note, however,
mortality has only been ascribed to cases of documented sarcoma
with dissemination.
Of the four disseminated sarcoma cases, three patients have
died (average survival 24.3 months); one remains alive 39 months
following her initial diagnosis. In contrast, the cases of LMS
without evidence of dissemination are alive with an average follow-
up of 29.7 months. These data are in line with reports by other
authors showing that disseminated disease secondary to morcel-
lation increases the mortality of LMS [8,19,22], and suggest that
iatrogenic implants of LMS behave biologically similarly to
metastases.
In the case of disseminated lesions of AL and STUMP, it is not
clear at this time if implants have any significant biologic
consequences. Additional follow-up is required to determine if
cases with peritoneal implants show any different outcomes than
those cases without such implants. The current length of follow-up
(averaging less than three years) may not be sufficient to identify
increased morbidity or mortality for dissemination of such lesions.
Distinguishing reactive changes status post surgery from
disseminated low- or intermediate-grade lesions can be challenging
because the amount of neoplastic tissue may be limited and the
neoplastic tissue may be admixed with fibrosis and chronic
inflammation reactive to tumor and/or surgical injury. Recogniz-
ing that myofibroblasts show similar immunohistochemical stain-
ing profiles to smooth muscle neoplasms, the best method to
distinguish neoplasm from reactive changes is comparison of
histology from the primary resections and potential disseminated
lesions. Case #18 is the only case identified thus far where the first
explorative laparoscopy revealed only benign disease but subse-
quent exploration revealed dissemination of the original malig-
nancy; it is possible that this case represents dissemination of both
benign and malignant tissue and that the malignant tissue was not
fully appreciated at the first exploratory laparoscopy. This further
supports the concern that given additional follow-up time more of
these cases will come to clinical attention with disseminated
disease.
In view of the challenges in these diagnoses, we recommend the
following procedures. In the case of solitary lesions, one section of
morcellated tissue should be submitted for histologic evaluation for
every 1 cm of the original radiologically reported greatest
dimension of the lesion. However, because cases with multiple
lesions also carry risk for unexpected diagnoses, we also
recommend generously sampling these cases, aiming to cut one
section per 1 cm of the dominant lesion(s), as well as several
sections representing any secondary lesions. Histologic evaluation
should be sure to sample any areas of yellow coloration (as
opposed to tan), any softened or ‘‘degenerated’’ areas, tissue
adjacent to necrosis, and any areas of hemorrhage, as, with en bloc
resections, these findings may correlate with a higher grade (i.e.
atypical or malignant) lesion.
For disseminated lesions we recommend comparing histology
between the primary tumor and the biopsies taken from
throughout the peritoneum. Histologically, the best indicator of
dissemination is the presence of bundles of smooth muscle cells
involving the peritoneal surface; in this series, infiltration/invasion
was not helpful in identifying these lesions, although if present it
would strongly suggest dissemination of the neoplastic lesion. It is
unclear if MiB-1 proliferation indices help in these cases, given the
small sample for which MiB-1 staining was performed in this
study; variable intensity and potential sampling issues further
limited these stains. The very low rate obtained in at least one
histologically malignant lesion (case #12), in particular, raises
concerns about the ability of this stain to reliably distinguish a low
grade from a high grade lesion. Nevertheless, no low grade lesions
showed indices above 10%, suggesting that a significantly elevated
MiB-1 proliferation index has a potentially high positive predictive
value.
The data presented here demonstrate that uterine lesions
believed preoperatively to represent benign leiomyomata may in
fact harbor atypical or malignant features at a clinically relevant
rate. Furthermore, the data show that the use of power
morcellation can be associated with the undesired outcome of
disseminating such lesions a high fraction of the time. The
histologic evaluation both of the primary and the disseminated
specimens is, therefore, of critical importance.
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